Development

INSIGHTS ON DRUG DEVELOPMENT

Fast And Efficient Processing Of ELISA Assays
Explore how a streamlined ELISA workflow using automated washing and reading tools enabled accurate detection of hepatitis B markers with no false results.
Immuno-Oncology Biomarker Measurement With High Sensitivity And Speed
Explore results demonstrating the successful use of innovative ELISA assays to detect three key biomarkers: Programmed Death Ligand 1 (PD-L1), Interleukin-8 (IL-8), and Interferon Gamma (IFN-γ).
Integration From Formulation Development To Manufacturing, Packaging
Adare Pharma Solutions' Pessano, Italy facility offers 220,000 sq. ft. of end-to-end services, including R&D, formulation development, clinical and commercial manufacturing, packaging, and advanced analytical capabilities.
Why DSC Testing Is A Critical Step In Developing Biosimilar Drugs
Explore the importance of testing in the regulatory process and how tools like Differential Scanning Calorimetry (DSC) are helping to bring more biosimilars to patients in need.

Improving Gene Therapy Development With Organ-On-A-Chip Technology
8/7/2024

Explore the current challenges of developing gene therapies, the potential of Organ-on-a-Chip technology, the future of gene therapy, and more.
Streamlining Biologics Development: Leveraging Small-Scale Studies For Greater Efficiency
9/25/2025

Uncover how a data-driven approach to small-scale studies not only accelerates development timelines but also enhances decision-making and resolves full-scale manufacturing challenges across diverse biologic modalities.
Quicker Development Using Cell Line Integration, End-To-End Support
6/19/2025

Despite challenges with mammalian host cell line diversity, Lonza's mitigation strategies drive efficiency and reproducibility, maximizing cell growth and product quality.
Automation Of 3D Intestinal Organoids Culture
3/17/2025

Gain insight into how 3D organoids promise better disease modeling and drug screening and how challenges like assay complexity, reproducibility, and scalability hinder their widespread adoption in drug discovery.
Developing A Quantitative Surrogate Peptide Assay
7/17/2025

Discover a streamlined LC-MS/MS workflow for Fc-containing therapeutics like dulaglutide to enable precise quantification with LLOQ as low as 1 ng/mL through automated, efficient assay development.

Why CorePharma?

End-to-end pharma manufacturing support unites development expertise and scalable production to accelerate the path from formulation to commercial supply with quality and flexibility.
Ergonomic System Microscopes for Complex Clinical Applications

Leica DM2000 LED - Ergonomic System Microscopes for Complex Clinical Applications
Rapid Sterility Testing: Actionable Results In Less Than 5 Hours

Use a real-time PCR (qPCR) solution for testing cell therapy products that provides sterility results in less than 5 hours.
Stereo Microscopes To Optimize Productivity And Production Quality
A60 F Stereo Microscope

Optimize your productivity and production quality

The intuitive A60 F and A60 S stereo microscopes fulfill what you need – high sample throughput, optimum visibility of product details and components, and easy processing of subassemblies.
- See 80% more of your sample with a 46 mm object field
- Comfortable access your sample due to the 122 mm working distance
- Easy handling, less refocusing and time saving with up to 13.6 mm depth of field and Leica FusionOptics technology
- Enables large surface overview and detailed observation with a magnification range from 5x to 30x
Psychedelics: Drug Development Capabilities

Learn how harnessing a CDMO’s extensive knowledge and skills in dealing with controlled substances can help you advance your innovative psychedelic therapeutic safely and efficiently.